161 related articles for article (PubMed ID: 37166199)
1. An Analysis of How Herpes Zoster Pain Affects Health-related Quality of Life of Placebo Patients From 3 Randomized Phase III Studies.
Matthews S; Curran D; Sabater Cabrera E; Boutry C; Lecrenier N; Cunningham AL; Schmader K
Clin J Pain; 2023 Aug; 39(8):386-393. PubMed ID: 37166199
[TBL] [Abstract][Full Text] [Related]
2. Natural History of Herpes Zoster in the Placebo Groups of Three Randomized Phase III Clinical Trials.
Curran D; Matthews S; Boutry C; Lecrenier N; Cunningham AL; Schmader K
Infect Dis Ther; 2022 Dec; 11(6):2265-2277. PubMed ID: 36322332
[TBL] [Abstract][Full Text] [Related]
3. Quality of Life Impact of an Adjuvanted Recombinant Zoster Vaccine in Adults Aged 50 Years and Older.
Curran D; Oostvogels L; Heineman T; Matthews S; McElhaney J; McNeil S; Diez-Domingo J; Lal H; Andrews C; Athan E; Berglund J; Campora L; de Looze F; Korhonen T; Leung E; Levin M; Volpi A; Johnson RW;
J Gerontol A Biol Sci Med Sci; 2019 Jul; 74(8):1231-1238. PubMed ID: 29955836
[TBL] [Abstract][Full Text] [Related]
4. Recombinant Zoster Vaccine Significantly Reduces the Impact on Quality of Life Caused by Herpes Zoster in Adult Autologous Hematopoietic Stem Cell Transplant Recipients: A Randomized Placebo-Controlled Trial (ZOE-HSCT).
Curran D; Matthews S; Rowley SD; Young JH; Bastidas A; Anagnostopoulos A; Barista I; Chandrasekar PH; Dickinson M; El Idrissi M; Heras I; Milliken ST; Monserrat Coll J; Navarro Matilla MB; Oostvogels L; Piątkowska-Jakubas B; Quiel D; Sabry W; Schwartz S; Selleslag DLD; Sullivan KM; Theunissen K; Yegin ZA; Yeh SP; Zaja F; Szer J;
Biol Blood Marrow Transplant; 2019 Dec; 25(12):2474-2481. PubMed ID: 31394276
[TBL] [Abstract][Full Text] [Related]
5. Impact of herpes zoster and postherpetic neuralgia on the quality of life of Germans aged 50 or above.
Curran D; Schmidt-Ott R; Schutter U; Simon J; Anastassopoulou A; Matthews S
BMC Infect Dis; 2018 Oct; 18(1):496. PubMed ID: 30285731
[TBL] [Abstract][Full Text] [Related]
6. Adjuvanted recombinant zoster vaccine decreases herpes zoster-associated pain and the use of pain medication across 3 randomized, placebo-controlled trials.
Kim JH; Johnson R; Kovac M; Cunningham AL; Amakrane M; Sullivan KM; Dagnew AF; Curran D; Schuind A
Pain; 2023 Apr; 164(4):741-748. PubMed ID: 36066965
[TBL] [Abstract][Full Text] [Related]
7. Burden of herpes zoster in the UK: findings from the zoster quality of life (ZQOL) study.
Gater A; Abetz-Webb L; Carroll S; Mannan A; Serpell M; Johnson R
BMC Infect Dis; 2014 Jul; 14():402. PubMed ID: 25038799
[TBL] [Abstract][Full Text] [Related]
8. The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults.
Schmader KE; Sloane R; Pieper C; Coplan PM; Nikas A; Saddier P; Chan IS; Choo P; Levin MJ; Johnson G; Williams HM; Oxman MN
Clin J Pain; 2007; 23(6):490-6. PubMed ID: 17575488
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.
Cunningham AL; Lal H; Kovac M; Chlibek R; Hwang SJ; Díez-Domingo J; Godeaux O; Levin MJ; McElhaney JE; Puig-Barberà J; Vanden Abeele C; Vesikari T; Watanabe D; Zahaf T; Ahonen A; Athan E; Barba-Gomez JF; Campora L; de Looze F; Downey HJ; Ghesquiere W; Gorfinkel I; Korhonen T; Leung E; McNeil SA; Oostvogels L; Rombo L; Smetana J; Weckx L; Yeo W; Heineman TC;
N Engl J Med; 2016 Sep; 375(11):1019-32. PubMed ID: 27626517
[TBL] [Abstract][Full Text] [Related]
10. Differential Utility Losses in Herpes Zoster Cases Between Vaccinated and Unvaccinated Subjects: A Meta-analysis of Three Clinical Trials.
Giannelos N; Francq B; Curran D
Clin Drug Investig; 2024 May; 44(5):293-301. PubMed ID: 38662318
[TBL] [Abstract][Full Text] [Related]
11. The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults ≥ 50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials.
Kim JH; Diaz-Decaro J; Jiang N; Hwang SJ; Choo EJ; Co M; Hastie A; Hui DSC; Irimajiri J; Lee J; Leung EM; Tang H; Tsuru T; Watson P; Wu Z; Yu CJ; Yuan Y; Zahaf T; Cunningham AL; Schuind A
Hum Vaccin Immunother; 2021 Jul; 17(7):2050-2057. PubMed ID: 33606577
[TBL] [Abstract][Full Text] [Related]
12. Effect of a zoster vaccine on herpes zoster-related interference with functional status and health-related quality-of-life measures in older adults.
Schmader KE; Johnson GR; Saddier P; Ciarleglio M; Wang WW; Zhang JH; Chan IS; Yeh SS; Levin MJ; Harbecke RM; Oxman MN;
J Am Geriatr Soc; 2010 Sep; 58(9):1634-41. PubMed ID: 20863322
[TBL] [Abstract][Full Text] [Related]
13. Complications of herpes zoster in immunocompetent older adults: Incidence in vaccine and placebo groups in two large phase 3 trials.
Kovac M; Lal H; Cunningham AL; Levin MJ; Johnson RW; Campora L; Volpi A; Heineman TC;
Vaccine; 2018 Mar; 36(12):1537-1541. PubMed ID: 29463421
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and serious adverse events profile of the adjuvanted recombinant zoster vaccine in adults with pre-existing potential immune-mediated diseases: a pooled post hoc analysis on two parallel randomized trials.
Dagnew AF; Rausch D; Hervé C; Zahaf T; Levin MJ; Schuind A;
Rheumatology (Oxford); 2021 Mar; 60(3):1226-1233. PubMed ID: 32910152
[TBL] [Abstract][Full Text] [Related]
15. Economic Burden and Impact on Quality of Life of Herpes Zoster in Spanish Adults Aged 50 Years or Older: A Prospective Cohort Study.
Díez-Domingo J; Curran D; Cambronero MDR; Garcia-Martinez JA; Matthews S
Adv Ther; 2021 Jun; 38(6):3325-3341. PubMed ID: 34013498
[TBL] [Abstract][Full Text] [Related]
16. Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory.
Coplan PM; Schmader K; Nikas A; Chan IS; Choo P; Levin MJ; Johnson G; Bauer M; Williams HM; Kaplan KM; Guess HA; Oxman MN
J Pain; 2004 Aug; 5(6):344-56. PubMed ID: 15336639
[TBL] [Abstract][Full Text] [Related]
17. Association between work time loss and quality of life in patients with Herpes Zoster: a pooled analysis of the MASTER studies.
Rampakakis E; Stutz M; Kawai K; Tsai TF; Cheong HJ; Dhitavat J; Ortiz-Covarrubias A; Cashat-Cruz M; Monsanto H; Johnson KD; Sampalis JS; Acosta CJ
Health Qual Life Outcomes; 2017 Jan; 15(1):11. PubMed ID: 28100258
[TBL] [Abstract][Full Text] [Related]
18. Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice.
Stadtmauer EA; Sullivan KM; El Idrissi M; Salaun B; Alonso Alonso A; Andreadis C; Anttila VJ; Bloor AJ; Broady R; Cellini C; Cuneo A; Dagnew AF; Di Paolo E; Eom H; González-Rodríguez AP; Grigg A; Guenther A; Heineman TC; Jarque I; Kwak JY; Lucchesi A; Oostvogels L; Polo Zarzuela M; Schuind AE; Shea TC; Sinisalo UM; Vural F; Yáñez San Segundo L; Zachée P; Bastidas A
Hum Vaccin Immunother; 2021 Nov; 17(11):4144-4154. PubMed ID: 34406911
[TBL] [Abstract][Full Text] [Related]
19. [Quality of life and risk factors in patients with herpes zoster].
Zhang Q; Huang ZS; Hu QQ; Qin W; Liang LL; Cui F; Wang Y; Pan F; Liu XL; Tang L; Ma C; Yin ZD; Wang FZ
Zhonghua Yi Xue Za Zhi; 2022 Nov; 102(42):3395-3400. PubMed ID: 36372770
[No Abstract] [Full Text] [Related]
20. Impact of Herpes Zoster and Post-Herpetic Neuralgia on Health-Related Quality of Life in Japanese Adults Aged 60 Years or Older: Results from a Prospective, Observational Cohort Study.
Mizukami A; Sato K; Adachi K; Matthews S; Holl K; Matsuki T; Kaise T; Curran D
Clin Drug Investig; 2018 Jan; 38(1):29-37. PubMed ID: 29086340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
